Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

With Its Stock Down 35%, This Dynamic Dividend Payer Thinks It's an Incredible BargainPhoto, wide shot, wide-angle lens,  Coal company, neutral atmosphere, photo by Galina Stepanova: https://img.theapi.app/temp/0e838f13-fa33-4583-92e9-bf3375dacf70.png
With Its Stock Down 35%, This Dynamic Dividend Payer Thinks It's an Incredible Bargain

Shares of Devon Energy (NYSE: DVN) have slumped about 35% over the past year. That's largely due to lower oil prices, which affected the company's oil-fueled variable dividend. The variable payout

Where Will Sea Limited Stock Be in 1 Year?
Where Will Sea Limited Stock Be in 1 Year?

Sea Limited's (NYSE: SE) stock price plunged 22% on Nov. 14 after the Singapore-based e-commerce and gaming specialist posted its third-quarter report. Revenue rose 5% year over year to $3.31

1 Exceptional Growth ETF That Could Turn $300 per Month Into $869,000
1 Exceptional Growth ETF That Could Turn $300 per Month Into $869,000

Investing in the stock market is a fantastic way to build long-term wealth, and exchange-traded funds (ETFs) are a smart option for those looking to potentially make a lot of money with very little

Can CRISPR Therapeutics Stock Double in 5 Years? Here's What It Would Take.Photo, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Can CRISPR Therapeutics Stock Double in 5 Years? Here's What It Would Take.

CRISPR Therapeutics (NASDAQ: CRSP) has reached a very exciting point in its story. The biotech company that specializes in gene editing is awaiting regulatory decisions on what could become its

This Retirement Account Could Be Your Key to Saving ThousandsPhoto, wide shot, wide-angle lens,  Retail store, neutral atmosphere, photo by Joe Cornish: https://img.theapi.app/temp/5574eb69-dc38-42f3-aadd-6163ac8bd4a8.png
This Retirement Account Could Be Your Key to Saving Thousands

Every person's retirement will indeed look different. You have people who wish to travel the world, some who want to pick up a new hobby, some who want to spend their days at the beach, and

Where Will Medtronic Stock Be in 5 Years?Photo, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Where Will Medtronic Stock Be in 5 Years?

The past five years haven't been great for medical device maker Medtronic (NYSE: MDT). Normally investors would expect a stock to generate positive gains over a five-year period, but Medtronic's

3 Small-Cap Stocks That Can Generate Life-Changing Wealth Over the Next 20 YearsPhoto, wide shot, wide-angle lens, soft focus,  Quarry, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-YQuR80w6IvxjemEoWYDXbEZo.png?st=2023-10-15T10%3A03%3A37Z&se=2023-10-15T12%3A03%3A37Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-10-14T14%3A03%3A01Z&ske=2023-10-15T14%3A03%3A01Z&sks=b&skv=2021-08-06&sig=/3q45HS%2B7KQiNIRh0W63diwmt7u%2BeQQMkMTkhvmYMtE%3D
3 Small-Cap Stocks That Can Generate Life-Changing Wealth Over the Next 20 Years

Investing on Wall Street comes with its inevitable ups and downs. Since this decade began, the iconic Dow Jones Industrial Average, broad-based S&P 500, and innovation-driven Nasdaq Composite have

After Its Stock Crashed 42% in 1 Day, Is Verve Therapeutics a Buy?
After Its Stock Crashed 42% in 1 Day, Is Verve Therapeutics a Buy?

Since reporting some early-stage clinical data from one of its gene editing programs on Nov. 12, share prices of Verve Therapeutics (NASDAQ: VERV) are down 42%. But contrary to what you may be

1 Small Chip Stock to Consider for a New Era of AIPhoto, wide shot, wide-angle lens, soft focus,  Networking equipment supplier, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-LvyAFCAMshu3rGBke5G5gxuI.png?st=2023-05-10T15%3A37%3A29Z&se=2023-05-10T17%3A37%3A29Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-10T02%3A36%3A27Z&ske=2023-05-11T02%3A36%3A27Z&sks=b&skv=2021-08-06&sig=nXxCmLby4SxAAd/YtNVxZStdXrs9BCydapQDQaR/oac%3D
1 Small Chip Stock to Consider for a New Era of AI

Silicon Motion Technology (NASDAQ: SIMO) is having a dramatic year. As if the nastiest consumer electronics downturn since the dot-com bubble weren't bad enough, it's also contending with legal

McDonald's Stock: Buy, Sell, or Hold?
McDonald's Stock: Buy, Sell, or Hold?

McDonald's (NYSE: MCD) stock has been a great investment, outperforming the market's average return over the last decade. But the stock has fallen 10% since hitting a new high earlier this year

A Stock Market Rally Is Coming: 1 Artificial Intelligence (AI) Growth Stock to Buy Now and 1 to Avoid, According to Wall StreetPhoto, wide shot, wide-angle lens,  Artificial intelligence developer, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/ee32e77c-b7d6-424b-91ea-4023f2292688.png
A Stock Market Rally Is Coming: 1 Artificial Intelligence (AI) Growth Stock to Buy Now and 1 to Avoid, According to Wall Street

Wall Street expects strong earnings to drive the stock market higher. The S&P 500 carries a consensus price target of 5,038, implying a 14% upside over the next year. That bottom-up forecast

Want $600 in Super Safe Annual Dividend Income? Invest $7,625 Into the Following 3 Infallible Ultra-High-Yield Stocks.Photo, wide shot, wide-angle lens, soft focus,  Asset management firm, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-4Gf80r47YD589EFtjlMy4oXE.png?st=2023-05-06T14%3A52%3A24Z&se=2023-05-06T16%3A52%3A24Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-06T00%3A39%3A24Z&ske=2023-05-07T00%3A39%3A24Z&sks=b&skv=2021-08-06&sig=d8x8qxYEsZ8AfRwcBw8eUkxkNQFVf9GobJgEag27Xug%3D
Want $600 in Super Safe Annual Dividend Income? Invest $7,625 Into the Following 3 Infallible Ultra-High-Yield Stocks.

There are a lot of ways to grow your nest egg on Wall Street. Investing in dividend stocks over the long run just happens to be a strategy with an exceptionally high return rate.

In 2013, the wealth

3 No-Brainer Discount Stocks That Smart Investors Are Scooping Up
3 No-Brainer Discount Stocks That Smart Investors Are Scooping Up

Do you like bargains? You should. Why pay more when you can buy something for less?

Well, the same idea applies to stocks. They sometimes go "on sale" by virtue of a price pullback. If it's a name

AbbVie and Pfizer Have 1 Thing in Common: Their Biggest Products Are on the Decline. Time to Sell?Photo, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
AbbVie and Pfizer Have 1 Thing in Common: Their Biggest Products Are on the Decline. Time to Sell?

AbbVie (NYSE: ABBV) and Pfizer (NYSE: PFE) are makers of two of the world's top-selling pharmaceutical products. AbbVie's immunology drug Humira brought in peak sales of more than $21 billion, while

Social Security Changes Are Coming in 2024: Here's the Good and the Bad
Social Security Changes Are Coming in 2024: Here's the Good and the Bad

Millions of older adults rely on Social Security to make ends meet in retirement, and for some, benefits are their sole income source.

Changes to the program can affect how much you receive

Sonos (SONO) Q4 2023 Earnings Call TranscriptPhoto, wide shot, wide-angle lens,  Consumer electronics manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/0defe5ca-333a-451e-9549-4f262e278fc7.png
Sonos (SONO) Q4 2023 Earnings Call Transcript

Image source: The Motley Fool.

Sonos (NASDAQ: SONO)Q4 2023 Earnings CallNov 15, 2023, 5:00 p.m. ET

Operator

Continue reading

Source Fool.com

Cisco Systems (CSCO) Q1 2024 Earnings Call TranscriptPhoto, wide shot, wide-angle lens,  Computer hardware manufacturer, sunset photo at golden hour, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/a130cb51-4ded-41be-b600-b83e2078ad65.png
Cisco Systems (CSCO) Q1 2024 Earnings Call Transcript

Image source: The Motley Fool.

Cisco Systems (NASDAQ: CSCO)Q1 2024 Earnings CallNov 15, 2023, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Palo Alto Networks (PANW) Q1 2024 Earnings Call Transcript
Palo Alto Networks (PANW) Q1 2024 Earnings Call Transcript

Image source: The Motley Fool.

Palo Alto Networks (NASDAQ: PANW)Q1 2024 Earnings CallNov 15, 2023, 4:30 p.m. ET

Walter Pritchard

Continue reading

Source Fool.com

Why Bitcoin and Other Cryptos Were Bouncing Higher Today:
Why Bitcoin and Other Cryptos Were Bouncing Higher Today

Will the current cryptocurrency rally ever end? Investors could be forgiven for thinking that it won't, on Wednesday, as prices of the leading asset in that class, Bitcoin (CRYPTO: BTC), and a large

Should AMD, Intel, and Nvidia Stock Investors Be Worried About Microsoft's New Chips?Photo, wide shot, wide-angle lens, soft focus,  Networking equipment supplier, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-LvyAFCAMshu3rGBke5G5gxuI.png?st=2023-05-10T15%3A37%3A29Z&se=2023-05-10T17%3A37%3A29Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-10T02%3A36%3A27Z&ske=2023-05-11T02%3A36%3A27Z&sks=b&skv=2021-08-06&sig=nXxCmLby4SxAAd/YtNVxZStdXrs9BCydapQDQaR/oac%3D
Should AMD, Intel, and Nvidia Stock Investors Be Worried About Microsoft's New Chips?

In today's video, I discuss recent updates impacting Microsoft (NASDAQ: MSFT), Advanced Micro Devices (NASDAQ: AMD), Intel (NASDAQ: INTC), and Nvidia (NASDAQ: NVDA). Check out the short video to

Why SunPower Stock Burned So Brightly on Wednesday
Why SunPower Stock Burned So Brightly on Wednesday

Hump Day didn't present much of an obstacle for SunPower (NASDAQ: SPWR) stock to advance. The solar company's shares gained more than 6% in price that day, comparing quite favorably to the 0.2% rise

Why Eli Lilly Stock Flopped While the Market Popped TodayPhoto, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
Why Eli Lilly Stock Flopped While the Market Popped Today

Wednesday's trading session was a good one for many stocks; a notable exception was pharmaceutical sector mainstay Eli Lilly (NYSE: LLY). The company's share price fell by almost 4% on the back of

Should Investors Buy the Dip in Upstart Stock?
Should Investors Buy the Dip in Upstart Stock?

Fool.com contributor Parkev Tatevosian reviews Upstart (NASDAQ: UPST) and its latest investor update to determine if investors should buy at current valuations.

*Stock prices used were the

Why Beyond Meat Stock Popped Today
Why Beyond Meat Stock Popped Today

Shares of Beyond Meat (NASDAQ: BYND) jumped as much as 12.6% early Wednesday, then settled to trade up around 6.7% as of 2:30 p.m. ET despite a lack of company-specific news.

As one of the most

Target Stock Up 17% on This Big News: Here's Why This High-Yield Stock Is Still a BuyPhoto, wide shot, wide-angle lens,  Retail store, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/add1012b-1b24-4eb2-aba0-77ab52c7f8ad.png
Target Stock Up 17% on This Big News: Here's Why This High-Yield Stock Is Still a Buy

Shares of Target (NYSE: TGT) surged after quarterly earnings but are still well down from the all-time high. In this video, Motley Fool contributor Jason Hall breaks down why the stock is worth